Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells, page-131

Re being "helpful" - I expect you're right. Hope so.

RAC probably has the most interactive input from shareholders of any biotech on the ASX, being filtered through you, I guess you would say. Anything else like it anywhere?

Did this actually help or hinder DCB I wonder. That's an interesting thought - to look at that situation from his perspective. Feels like a "hospital pass" pondering it now. I wonder how he feels. I wonder if he's still a shareholder.

So RAC as we know it, now with you as the largest shareholder, has a shareholder participation model unlike any other ... which combined with the link to Merchant ... Q3 T20 data not far off.

And now you're the consultant representative of the Exec.

I'm glad you're back and hope you can help steer the ship into better seas.